title: Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis.
abstract: The temporal relationship of hepatic steatosis and changes in liver oxidative stress and fatty acid (FA) composition to the development of non-alcoholic steatohepatitis (NASH) remain to be clearly defined. Recently, we developed an experimental model of hepatic steatosis and NASH, the transgenic spontaneously hypertensive rat (SHR) that overexpresses a dominant positive form of the human SREBP-1a isoform in the liver. These rats are genetically predisposed to hepatic steatosis at a young age that ultimately progresses to NASH in older animals. Young transgenic SHR versus SHR controls exhibited simple hepatic steatosis which was associated with significantly increased hepatic levels of oxidative stress markers, conjugated dienes, and TBARS, with decreased levels of antioxidative enzymes and glutathione and lower concentrations of plasma alpha- and gamma-tocopherol. Transgenic rats exhibited increased plasma levels of saturated FA, decreased levels of n-3 and n-6 polyunsaturated FA (PUFA), and increased n-6/n-3 PUFA ratios. These results are consistent with the hypothesis that excess fat accumulation in the liver in association with increased oxidative stress and disturbances in the metabolism of saturated and unsaturated fatty acids may precede and contribute to the primary pathogenesis of NASH.
authors.affiliation: Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
authors.forename: Hana
authors.initials: H
authors.lastname: Malínská
authors.forename: Olena
authors.initials: O
authors.lastname: Oliyarnyk
authors.forename: Miriam
authors.initials: M
authors.lastname: Hubová
authors.forename: Václav
authors.initials: V
authors.lastname: Zídek
authors.forename: Vladimír
authors.initials: V
authors.lastname: Landa
authors.forename: Miroslava
authors.initials: M
authors.lastname: Simáková
authors.forename: Petr
authors.initials: P
authors.lastname: Mlejnek
authors.forename: Ludmila
authors.initials: L
authors.lastname: Kazdová
authors.forename: Theodore W
authors.initials: TW
authors.lastname: Kurtz
authors.forename: Michal
authors.initials: M
authors.lastname: Pravenec
mesh_terms: D000818:Animals; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D005234:Fatty Liver / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D020022:Genetic Predisposition to Disease; D006801:Humans; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D018384:Oxidative Stress; D051381:Rats; D011918:Rats, Inbred SHR; D055647:Rats, Transgenic; D051780:Sterol Regulatory Element Binding Protein 1 / Q000235:genetics* / Q000378:metabolism
chemical_list: D005231:Fatty Acids, Unsaturated; C497387:SREBF1 protein, human; D051780:Sterol Regulatory Element Binding Protein 1